Jan 10 (Reuters) - LIDDS AB:
* REG-LIDDS: NANOZOLID® WITH IMMUNE-STIMULATING AGENT CONFIRMS EFFICACY IN AN ADDITIONAL CANCER MODEL
* SAYS ‍CLEAR ANTI-TUMOR EFFECTS HAVE BEEN OBSERVED IN ANOTHER CANCER MODEL IN MICE​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)
Our Standards: The Thomson Reuters Trust Principles.